Literature DB >> 10789936

Effect on lung function of continuous positive airway pressure administered either by infant flow driver or a single nasal prong.

V Kavvadia1, A Greenough, G Dimitriou.   

Abstract

UNLABELLED: The aim of this study was to assess if continuous positive airways pressure (CPAP) delivered by an infant flow driver (IFD) was a more effective method of improving lung function than delivering CPAP by a single nasal prong. A total of 36 infants (median gestational age 29 weeks, range 25-35 weeks) were studied, 12 who received CPAP via an IFD, 12 who received CPAP via a single nasal prong and 12 without CPAP. CPAP was administered post extubation if apnoeas and bradycardias or a respiratory acidosis developed or electively if the infant was of birth weight <1.0 kg. Lung function was assessed by the supplementary oxygen requirement and measurement of compliance of the respiratory system using an occlusion technique. Assessments were made immediately prior to and after 24 h of CPAP administration and at similar postnatal ages in the non-CPAP group. The infants who did not require CPAP had better lung function (non significant) than the other two groups before they received CPAP. After 24 h, lung function had improved in both CPAP groups to the level of the non CPAP infants. The supplementary oxygen requirements of all three groups decreased over the 24 h period, but this only reached significance in the single nasal prong group (P<0.05). Four infants supported by the IFD, but none with a single nasal prong, became hyperoxic.
CONCLUSION: Continuous positive airways pressure administration via the infant flow driver appears to offer no short-term advantage over a single nasal prong system when used after extubation in preterm infants.

Entities:  

Mesh:

Year:  2000        PMID: 10789936     DOI: 10.1007/s004310050072

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

1.  In vitro comparison of nasal continuous positive airway pressure devices for neonates.

Authors:  A G De Paoli; C J Morley; P G Davis; R Lau; E Hingeley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

Review 2.  CPAP review.

Authors:  Olie Chowdhury; Catherine J Wedderburn; Donovan Duffy; Anne Greenough
Journal:  Eur J Pediatr       Date:  2011-12-16       Impact factor: 3.183

3.  A randomised control study comparing the Infant Flow Driver with nasal continuous positive airway pressure in preterm infants.

Authors:  M Mazzella; C Bellini; M G Calevo; F Campone; D Massocco; P Mezzano; E Zullino; F Scopesi; C Arioni; W Bonacci; G Serra
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

4.  A randomised controlled trial of two methods of delivering nasal continuous positive airway pressure after extubation to infants weighing less than 1000 g: binasal (Hudson) versus single nasal prongs.

Authors:  P Davis; M Davies; B Faber
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

5.  Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial.

Authors:  F Sandri; G Ancora; A Lanzoni; P Tagliabue; M Colnaghi; M L Ventura; M Rinaldi; I Mondello; P Gancia; G P Salvioli; M Orzalesi; F Mosca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

Review 6.  Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.

Authors:  A G De Paoli; P G Davis; B Faber; C J Morley
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.